Cargando…
Optimization of Pyrazole Compounds as Antibiotic Adjuvants Active against Colistin- and Carbapenem-Resistant Acinetobacter baumannii
The diffusion of antibiotic-resistant, Gram-negative, opportunistic pathogens, an increasingly important global public health issue, causes a significant socioeconomic burden. Acinetobacter baumannii isolates, despite causing a lower number of infections than Enterobacterales, often show multidrug-r...
Autores principales: | Sannio, Filomena, Brizzi, Antonella, Del Prete, Rosita, Avigliano, Marialuce, Simone, Tiziana, Pagli, Carlotta, Ferraro, Teresa, De Luca, Filomena, Paolino, Marco, Corelli, Federico, Mugnaini, Claudia, Docquier, Jean-Denis |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9774939/ https://www.ncbi.nlm.nih.gov/pubmed/36551489 http://dx.doi.org/10.3390/antibiotics11121832 |
Ejemplares similares
-
Colistin Plus Carbapenem versus Colistin Monotherapy in the Treatment of Carbapenem-Resistant Acinetobacter baumannii Pneumonia
por: Shi, HyeJin, et al.
Publicado: (2019) -
Colistin, Hot Potato for the Therapy of Carbapenem-resistant Acinetobacter baumannii infections
por: Park, Sang-Won
Publicado: (2019) -
Survival of carbapenem-resistant Acinetobacter baumannii bacteremia: colistin monotherapy versus colistin plus meropenem
por: Park, So Yeon, et al.
Publicado: (2019) -
Tigecycline Versus Colistin in the Treatment of Carbapenem-resistant Acinetobacter baumannii Complex Osteomyelitis
por: Oliveira, Priscila R., et al.
Publicado: (2020) -
In Vitro Synergy of Colistin in Combination with Meropenem or Tigecycline against Carbapenem-Resistant Acinetobacter baumannii
por: Abdul-Mutakabbir, Jacinda C., et al.
Publicado: (2021)